Novel drug may take on lung cancer | Science News

Be a Champion for Science

Get your subscription to

Science News when you join.


Novel drug may take on lung cancer

12:50pm, May 3, 2005

In several kinds of cancer, malignant cells display an excess of a specific type of surface receptor, which when stimulated causes unchecked growth of such cells (SN: 9/11/04, p. 164: Available to subscribers at An Exploitable Mutation: Defect might make some lung cancers treatable).

Scientists now report that a novel agent bottles up this so-called epidermal growth factor receptor and stalls the growth of cancer cells in a lab dish. The strong results have led the researchers to begin testing the new drug, called HKI-272, in people with lung cancer that has proved resistant to two existing anticancer drugs that target the same receptor, reports Daniel A. Haber of Massachusetts General Hospital Cancer Center in Charlestown.

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from this issue of Science News